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Abstract
Chlamydia pneumoniae (CP) is associated with induction and exacerbation of asthma. CP infection can induce allergic airway
sensitization in mice in a dose- and time-dependent manner. Allergen exposure 5 days after a low dose (mild-moderate),
but not a high dose (severe) CP infection induces antigen sensitization in mice. Innate immune signals play a critical role in
controlling CP infection induced allergic airway sensitization, however these mechanisms have not been fully elucidated.
Wild-type, TLR22/2, and TLR42/2 mice were infected intranasally (i.n.) with a low dose of CP, followed by i.n. exposure to
human serum albumin (HSA) and challenged with HSA 2 weeks later. Airway inflammation, immunoglobulins, eosinophils,
and goblet cells were measured. Low dose CP infection induced allergic sensitization in TLR22/2 mice, but not in TLR42/2
mice, due to differential Treg responses in these genotypes. TLR22/2 mice had reduced numbers of Tregs in the lung
during CP infection while TLR42/2 mice had increased numbers. High dose CP infection resulted in an increase in Tregs
and pDCs in lungs, which prevented antigen sensitization in WT mice. Depletion of Tregs or pDCs resulted in allergic airway
sensitization. We conclude that Tregs and pDCs are critical determinants regulating CP infection-induced allergic
sensitization. Furthermore, TLR2 and TLR4 signaling during CP infection may play a regulatory role through the modulation
of Tregs.
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Introduction
Asthma is characterized by an inappropriate immune response
that results in bronchoconstriction, mucus secretion, and eosino-
philic airway inflammation, and is thought to develop in two stages
[1]. The first stage, known as sensitization, encompasses the
exposure to a normally innocuous antigen in the lungs during
some type of inflammatory response that leads to the development
of Th2 type memory cells [2]. Later, upon re-exposure to the same
antigen, these memory cells are activated, resulting in an
inflammation of the lungs. There are many possible mechanisms
for antigen sensitization to occur, and one increasingly important
scenario involves respiratory infections.
It is known that respiratory viral infections among young
children can lead to a much greater risk of asthma development
[3]. Experimental studies using murine models have also shown
that pulmonary viral infections can enhance antigen sensitization
and or lead to exacerbation of asthma, depending on the timing
and severity of infection [4,5]. However, much less is known about
the interactions of bacterial infections and asthma. Chlamydia
muridarum infection in the lungs of neonatal mice results in a more
severe asthma phenotype later on in life [6] and many clinical
studies have linked the bacterial pathogen, Chlamydia pneumoniae
(CP) with both the development and exacerbation of asthma
[7,8,9]. Murine studies showed that a mild pulmonary CP
infection could act as an adjuvant for antigen sensitization to an
otherwise inert protein (human serum albumin (HSA)), which
upon re-exposure to HSA resulted in eosinophilic airway
inflammation and goblet cell hyperplasia [10]. Interestingly,
allergic airway sensitization critically depended on the severity
and timing of CP infection, as a low-dose (mild) infection and
antigen exposure within 5 days of infection induced allergic
sensitization, whereas high-dose (severe) CP infection or antigen
exposure 10 days after infection did not [10]. Temporal and dose-
related effects on the ability of CP infection to induce allergic
sensitization reflected DC activation and could be reproduced by
means of adoptive transfer of HSA-pulsed lung DCs from infected
mice, and be modulated by Treg cells [10].
In this study, we now provide additional mechanistic insights on
the specific roles of Treg cells and plasmacytoid DCs in the
temporal and dose-related allergic sensitization induced by CP
infection. We show that TLR4 signaling is required for antigen
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e20784sensitization, but TLR2 is not, and that Tregs are involved in both
phenotypes. Additionally, we find that during a severe CP
infection, which is normally non-permissive for allergic sensitiza-
tion in this murine model, both Tregs and plasmacytoid dendritic
cells (pDCs) are increased in the lung and that the depletion of
either cell type results in the reversal of the phenotype and allows
development of allergic sensitization. In further mechanistic
investigations we observed that in addition to a live CP infection,
UV killed CP (CPUV) can also induce allergic sensitization and we
show that this observation is not specific to pulmonary CP
infection but can occur with other bacteria as well, as UV killed
Bordetella bronchiseptica was also able to induce allergic sensitization
to HSA. Indeed, we show that bacterial ligands, such as a TLR2
ligand, in addition to the TLR4 ligand LPS, are able to induce the
allergic sensitization. Collectively these data now provide strong
evidence that killed CP, or other bacteria such as Bordetella
bronchiseptica, as well as TLR2 ligands can induce allergic
sensitization, and that during a live CP infection, both Tregs
and pDCs critically regulate the temporal and dose-dependent
induction of allergic airway sensitization. Additionally, TLR2 and
TLR4 signaling during CP infection may play a regulatory role
though the modulation of Tregs.
Results
UV killed C. pneumoniae and UV killed Bordetella
bronchiseptica induce antigen sensitization and
eosinophilic airway inflammation
We wished to investigate if in addition to live CP infection [10],
UV killed CP (CPUV) could also induce allergic sensitization and
if so, try and break down the relative importance of various PAMP
signals during infection towards antigen sensitization. Mice were
exposed to 1610
6 CPUV in combination with 100 mg human
serum albumin (HSA) or PBS control intranasally, then re-exposed
to HSA two weeks later (Fig S1A). Upon re-exposure to HSA,
mice that were initially exposed to HSA and CPUV developed
significant inflammation in the lungs as determined by H&E
staining (Figure 1A). In contrast, mice that received HSA without
CPUV during sensitization, or mice that were challenged with
PBS instead of HSA did not develop pulmonary inflammation.
Similarly, mice sensitized with HSA and CPUV, followed by HSA
challenge, had significantly increased eosinophils in the lung
compared to controls (Figure 1B). Significant goblet cell
hyperplasia was also found in mice that received both HSA and
CPUV during sensitization, and HSA challenge (Figure 1C).
Finally, HSA-specific IgE and IgG1 levels were significantly
increased in mice that were sensitized with both HSA and CPUV,
while IgG2a levels were unchanged (Figure 1D). These data
indicate that CPUV can also act as a potent adjuvant and drive
antigen sensitization. We next wanted to determine if this
observation was specific to CPUV or if it could be induced with
another bacterial adjuvant. We used UV killed Bordetella
bronchiseptica (BBUV). Mice were exposed to 1610
6 CFU BBUV
in combination with 100 mg human serum albumin (HSA) or PBS
control intranasally, then re-exposed to HSA two weeks later as
described above. Upon re-exposure to HSA, mice that were
initially exposed to HSA and BBUV also developed significant
inflammation in the lungs as well as significantly increased
infiltration of eosinophils, goblet cells, and HSA-specific IgE and
IgG1 (Fig S2A–D), similar to findings obtained by CPUV. These
observations clearly suggest that killed bacteria other than CP can
also induce allergic sensitization, implying that various microbial
ligands present in killed bacteria are most likely able to drive this
antigen sensitization.
TLR2 signaling can drive antigen sensitization
It is known that innate immune cells can detect Chlamydia
pneumoniae by both TLR2 and TLR4 pattern recognition receptors
(PRR) [11,12]. However, C. pneumoniae uses predominantly TLR2
signaling for cytokine release [12,13]. MyD88 signaling is essential
for CP infection induced antigen sensitization in this allergic
asthma model [10]. Both TLR2 and TLR4 signaling can proceed
through MyD88, and since the role of a TLR4 ligand, LPS alone
in this antigen sensitization model has already been described [14],
we investigated whether TLR2 signaling by itself could also induce
antigen sensitization in this model. Using the same protocol as
above, except substituting CPUV with either LP2 (TLR2 ligand)
or LPS (TLR4 ligand), upon subsequent challenge with HSA, mice
that were sensitized in the presence of either LPS or LP2
developed both eosinophilic airway inflammation and goblet cell
hyperplasia (Figure 2A–B), while the control mice did not. As far
as we are aware, this is the first reported instance of a TLR2 ligand
driving allergic antigen sensitization in the lung.
Airway sensitization by C. pneumoniae requires TLR4-
but not TLR2- dependent signaling
We next investigated the roles of TLR2 and TLR4 signaling
during live CP infection induced antigen sensitization. Since CP
signals predominantly through TLR2 for cytokine release, and
that a TLR2 ligand, LP2 alone could drive antigen sensitization,
we hypothesized that CP infection-induced allergic sensitization
would not be seen in TLR22/2 mice, but would be observed in
TLR42/2 mice. Utilizing our previously published protocol for
live infection induced antigen sensitization (Fig S1B) [10], WT,
TLR22/2, TLR42/2, and TRIF2/2 mice were infected with
5610
5 IFU of CP, sensitized with HSA for three days (beginning 5
days after infection), and then challenged with HSA. As expected
WT mice developed allergic sensitization with eosinophilia and
goblet cell hyperplasia in the lungs of mice that were infected with
CP and sensitized/challenged with HSA (Figure 2C–D). However,
we observed that TLR22/2 mice were successfully sensitized,
while TLR42/2 mice were not. Indeed, TLR22/2 mice
developed increased eosinophils and goblet cells in the lung, while
TLR42/2 mice did not (Figure 2C–D), suggesting that CP-
induced allergic sensitization requires TLR4 but not TLR2. TLR4
can signal through both MyD88 and TRIF. MyD88 signaling is
absolutely required for CP infection induced antigen sensitization
[10], but the role of TRIF signaling is unknown. Therefore we
investigated whether TRIF2/2 mice could be sensitized by live
CP infection. We observed that TRIF was not important in
infection-induced allergic sensitization as TRIF2/2 mice devel-
oped allergic sensitization and were indistinguishable from WT
mice (Figure 2C–D). In order to dissect the molecular mechanisms
as to why TLR22/2 mice but not TLR42/2 mice could be
sensitized, we investigated the relative activation of TLR22/2
and TLR42/2 bone marrow derived dendritic cells (BMDCs) by
CP infection. BMDCs were exposed to live CP, LPS, LP2, or
CPUV for 24 hrs and IL-6 levels in the supernatants were
measured. LPS, LP2, CP, and CPUV all induced IL-6 production
in WT BMDCs, as expected (Fig S3A). In BMDCs obtained from
TLR42/2 mice, LPS did not induce IL-6, LP2 exposure was
unchanged from wild type mice, while both live and UV killed C.
pneumoniae still induced IL-6, but at lower levels than WT cells. On
the other hand, TLR22/2 BMDCs responded to LPS, and but
not to the TLR2 ligand LP2 as expected, but showed substantially
reduced IL-6 release in response to live-CP and to CPUV
compared to WT and TLR42/2 BMDCs. While these data
corroborate previously published data that CP signals mainly
through TLR2 for cytokine release, they do not explain the lack of
Tregs Control CP Infection Induced Sensitization
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activation state of the BMDCs after exposure to CP in order to
discern any differential responses between TLR2- and TLR4-
deficient BMDCs. Both TLR22/2 and TLR42/2 BMDCs had
reduced levels of CD80 and CD86 expression on the surface
compared to WT BMDCs after CP exposure (Fig S3B). Again,
these data did not provide any explanation for the differential
sensitization observed between TLR22/2 and TLR42/2 mice.
We next studied the role of Tregs in these two genotypes. Previous
reports revealed that TLR22/2 mice had reduced circulating
numbers of Tregs [15,16]. Since Tregs play an important
suppressive role in the development of asthma [17,18] we
therefore investigated the numbers of Tregs in these mice during
infection. WT, TLR22/2 and TLR42/2 mice were infected
Figure 1. Parallel exposure of mice to CPUV and HSA induces allergic airway sensitization. A: Inflammatory scores of H&E stained lung
sections of mice after sensitization and challenge. Shown below are representative sections. B: Staining of lung sections for eosinophil-specific
peroxidase. Total numbers of eosinophils were related to the total area of the section. Shown below are representative sections. C: Goblet cells
visualized by PAS staining. Total numbers of goblet cells were related to the total length of bronchial basal membrane in the section. Representative
sections are shown below. D: HSA-specific IgE, IgG1 and IgG2a titers. *p#0.05, **p#0.01, ***p#0.001.
doi:10.1371/journal.pone.0020784.g001
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assessed by flow cytometry 5 days after infection. We observed that
baseline levels of Tregs in the lung were significantly reduced in
TLR22/2 mice compared to WT and TLR42/2 mice
(Figure 2E, Figure S4A), which was maintained at 5 days after
infection, during the time when sensitization would begin.
Additionally, TLR42/2 mice now had a significant increase in
Tregs as compared to WT mice (Figure 2E). The reduced
numbers of Tregs in TLR22/2 mice provide a possible
explanation for the ability of TLR22/2 mice to be sensitized,
despite reduced activation and responsiveness in their dendritic
cells. Conversely, the inability of TLR42/2 mice to be sensitized
Figure 2. The effects of TLR signaling on CP infection induced antigen sensitization. A and B: Administration of HSA to mice in the
presence of TLR2- or TLR4-ligands induces airway sensitization. Mice were sensitized with either HSA alone (n=8), 100 ng Pam2CSK4 (LP2) alone
(n=4), HSA+100 ng LP2 (n=8), 100 ng LPS alone (n=4) or HSA+100 ng LPS (n=5). Mice were challenged with HSA and eosinophil and goblet cell
numbers were assessed. C and D: Wild type (WT) (n=7), TLR22/2 (n=7), TLR42/2 (n=7) and TRIF2/2 (n=8) mice were infected with 5610
5 CP
followed by HSA sensitization and challenge as shown in Figure 1B. Eosinophil and goblet cell numbers were assessed. E: Percentage of lung Tregs in
wild type, TLR22/2, and TLR42/2 uninfected and CP-infected mice. Wild type, TLR42/2, and TLR22/2 mice (n=3–6 per group) were inoculated
with 5610
5 IFU of CP. 5 days after inoculation, mice were sacrificed, lung leukocyte preparations were generated and analyzed for the presence of
CD4+, CD25+, Foxp3+ Tregs by flow cytometry. Data are presented as a percentage of total lung cells. Shown are combined data from 2–3 separate
experiments. *p#0.05, **p#0.01.
doi:10.1371/journal.pone.0020784.g002
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their lungs.
Treg depletion in TLR42/2 mice allows allergic
sensitization by C. pneumoniae infection
Since the infected TLR42/2 mice had increased levels of
Tregs in the lungs during the sensitization period (Figure 2E), we
decided to directly test whether these Tregs were preventing
allergic sensitization. Using the same model as above, TLR42/2
mice were given the PC61 antibody (or IgG control) one day prior
to sensitization to deplete the Tregs during the sensitization
window. In agreement with our hypothesis, the depletion of Tregs
in TLR42/2 mice reversed the phenotype and allowed allergic
sensitization with eosinophilia and goblet cell hyperplasia in these
mice (Figure 3A–B). Additionally, HSA specific IgE and IgG1
were also significantly increased in these mice (Figure 3C).
Importantly, in a control experiment, uninfected mice that
received the PC61 antibody during sensitization did not develop
an allergic airway response to HSA. These observations suggest
that Tregs prevent antigen sensitization in TLR42/2 mice
infected with CP.
TLR22/2 mice have an extended time-window for C.
pneumoniae infection induced antigen sensitization
Tregs control the time window during which WT mice could be
sensitized relative to the start of the CP infection [10]. Normally,
WT mice could be sensitized 5 days after low-dose (mild) infection,
but not 10 days after, due to an influx of Tregs [10]. However, if the
Tregs were depleted, the mice could now be sensitized 10 days after
infection [10]. We reasoned that since TLR22/2 mice had
reduced numbers of lung Tregs at baseline, and did not increase
their Treg numbers 5 days after infection, they should be able to
develop sensitization even at day 10 after infection if Treg played a
critical role in this event. We infected TLR22/2 and WT mice as
before and sensitized them with HSA 10 days after infection instead
of 5 days (Fig S1B). We observed that TLR22/2 mice had
significantly reduced Tregs 10 days after infection compared to WT
mice (Figure 4A, Figure S4B). As we predicted, we observed that
TLR22/2 mice can develop allergic sensitization when the
antigen is introduced initially both at day 5 and day 10 after
infection, while WT mice is sensitized only when antigen is given at
day 5 but not day 10 after infection (Figures 4B–D and 2C–D).
Importantly, in control experiments, uninfected TLR22/2 mice
Figure 3. Treg depletion allows CP infection induced antigen sensitization in TLR42/2 mice. TLR42/2 mice received either CP+PC61
mAB (n=8), CP+IgG control (n=7), PBS+PC61 mAB (n=8), or PBS+IgG control (n=6), and were sensitized and challenged with HSA as described in
Figure 1C. A: Staining of lung sections for eosinophil-specific peroxidase. Total numbers of eosinophils were related to the total area of the section.
B: Goblet cells visualized by PAS staining. Total numbers of goblet cells were related to the total length of bronchial basal membrane in the section.
C: HSA-specific IgE, IgG1, and IgG2a titers. *p#0.05, **p#0.01, ***p#0.001.
doi:10.1371/journal.pone.0020784.g003
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reduced in these mice, CP infection was still required as an adjuvant
for antigen sensitization to occur. These observations, while not
providing definitive proof, strongly suggest that the reduced
numbers of Tregs in TLR22/2 mice likely allowed for the
extended time window for allergic sensitization and support the
conclusion that Tregs critically regulate infection-induced allergic
sensitization.
Severe C. pneumoniae infection increases Tregs and
pDCs in the lung
In our earlier publication, we reported that dose-dependence or
infection severity was a determinant for antigen sensitization [10].
A moderate low dose infection (5610
5 IFU) induced antigen
sensitization, while a severe high dose infection (5610
6 IFU)
prevented sensitization from occurring. Given the importance of
Tregs during CP infection-induced antigen sensitization, we
investigated whether Tregs might also play an inhibitory role
during a severe (high-dose) CP infection. We infected WT mice
with either 5610
5 or 5610
6 IFU CP and examined the number of
Tregs in the lungs 5 days after infection by flow cytometry. There
was no significant change in Treg numbers in lungs between
uninfected mice and low dose infected mice at day 5 (Figure 5A).
However, we observed a dramatic and significant increase of
Tregs in the lungs of mice in the high-dose infection group,
compared to low-dose infection group and uninfected control mice
(Figures 5A, Figure S4C). We also investigated Plasmacytoid
Dendritic cells (pDCs), another cell type that plays a suppressive
role towards antigen sensitization. Like Tregs, pDCs were
significantly increased during a severe CP infection compared to
uninfected mice (Figure 5B, Figure S4D). However, the pDCs
were also increased in the low dose infection group as well,
Figure 4. TLR22/2 mice have an extended time window for CP infection induced antigen sensitization. A: Tregs were assessed in the
lungs of WT and TLR22/2 mice 10 days after low dose (5610
5) CP infection. Data are presented as CD4+, CD25+, FoxP3+ Tregs as percentage of total
lung cells. B–D: WT infected mice (n=8), and TLR22/2 mice infected (n=8) and uninfected (n=8) were sensitized and challenged with HSA as
described in Figure 1D. Inflammation (B), Eosinophils (C) and Goblet cells (D) were scored for as before. *p#0.05, **p#0.01, ***p#0.001.
doi:10.1371/journal.pone.0020784.g004
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representative flow cytometric scatterplots of Tregs and pDCs
during infection, see Figure S4E–F. Thus two suppressive cell
types towards antigen sensitization, Tregs and pDCs, were present
in greater numbers during a severe CP infection in WT mice,
compared to the moderate infection group, likely preventing
antigen sensitization.
Treg depletion allows antigen sensitization to occur
during severe C. pneumoniae infection
In order to determine if the increased Tregs in the lung during a
severe CP infection played a critical role in preventing antigen
sensitization, we depleted Tregs during the course of sensitization.
Specific depletion of Tregs was made possible by the use of the
Foxp3-specific human diphtheria toxin receptor (DTR) transgenic
mice (FoxP3-DTR-tg), in which all Foxp3 Treg cells express
human diphtheria toxin (DT) receptor (DTR) and, therefore can
be efficiently eliminated upon treatment with DT [19,20]. FoxP3-
DTR-tg mice were infected with high dose (5610
6 IFU) CP and
sensitized 5 days later as before. However, at one day before and
on the second day of sensitization, 1 mg of diphtheria toxin (DT),
or PBS control, was injected i.p. into the mice to selectively deplete
Tregs (Fig S1C) during sensitization. The mice were then
challenged and sacrificed as before. Lung Treg depletion was
nearly 100% one day after DT injection as shown in Figure 6A by
flow cytometry. Specific depletion of Treg cells during the
sensitization period in high-dose CP- infected FoxP3-DTR-tg
mice reversed the phenotype and allowed the high dose infection
to result in allergic sensitization with significantly increased
recruitment of eosinophils in the lungs (Figure 6B, 6D) as well as
goblet cell hyperplasia, compared to infected FoxP3-DTR-tg mice
that did not receive DT (Figure 6C, 6E). Both PBS control and
uninfected DT controls did not respond to antigen challenge.
Thus both infection and Treg depletion was required for
sensitization to occur. We isolated mediastinal lymph nodes
8 days after the conclusion of sensitization from infected and
Treg-depleted mice and restimulated the lymphocytes with HSA
and observed significantly increased IL-5 production in response
to antigen stimulation compared to control mice with undepleted
Tregs (Figure 6F). Additionally, HSA specific IgE and IgG1 were
significantly increased in the serum of the infected and Treg-
depleted mice (Figure 6G). Not surprisingly since there was a
severe intracellular infection, HSA specific IgG2a, a Th1 isotype,
was also increased in these mice (Figure 6G). Thus Treg depletion
allowed for the generation of antigen specific Th2 cells that
resulted in allergic sensitization and eosinophilic airway inflam-
mation upon restimulation with the same antigen.
pDC depletion also allows antigen sensitization to occur
during severe C. pneumoniae infection
During high dose CP infection, a condition that does not allow
allergic sensitization, we also observed significantly increased pDC
numbers in the lungs, in addition to increased number of Tregs,
compared to low-dose infection group as shown above (Figure 5B).
Given the known interaction between pDCs and Tregs [21], and
the fact that pDCs can also have a suppressive effect on allergic
sensitization [22,23], we next sought to determine if the increased
pDCs numbers in the lungs observed during high dose CP
infection may have also contributed to suppression of antigen
sensitization in this group of mice. To test this possibility, we
infected WT mice with a high dose of CP and depleted their pDCs
using a pDC-specific depleting antibody (mAb927 [24]) (Fig S1C
and Figure 7A) during the sensitization window. pDC-depletion
allowed the high-dose CP-infected mice to become sensitized
compared to non-depleted controls (Figure 7B–D). pDC-depleted
uninfected controls did not develop an allergic airway response.
Taken together, our data suggest that in addition to Tregs, pDCs
can also provide a suppressive signal preventing bacterial
pulmonary infection-induced allergic asthma sensitization in case
of high-dose infection, and that these two regulatory cell types
work in concert to regulate the temporal and dose dependent
adjuvant effects of the infection.
Figure 5. Tregs and pDCs are induced during high dose CP infection. A–C: WT mice were infected with either low dose (5610
5) or high dose
(5610
6) CP intranasally. 5 days after infection, the lungs were harvested and single cell suspensions were analyzed by flow cytometry. A: Tregs. Data
are presented as CD4+, CD25+, FoxP3+ Tregs as a percentage of total lung cells. B: pDCs. Data are presented as BST2+, B220+, CD3 CD19 CD11b- and
side scatter low as a percentage of total lung cells. *p#0.05, **p#0.01, ***p#0.001.
doi:10.1371/journal.pone.0020784.g005
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Chlamydia pneumoniae lung infection can trigger allergic airway
sensitization against an inert inhaled antigen, and that this is depe-
ndent on the severity and timing of infection [10]. In this study, we
observed that in addition to live CP infection, UV killed CP is also
able to act as adjuvant and can trigger successful antigen
sensitization. UV killed CP provides ligands for both TLR2 and
TLR4 [11,12,13], and potentially NOD1 and NOD2 [25], which
can likely induce sensitization. Indeed, our results using LPS (TLR4
ligand)orLP2(TLR2ligand) areinagreement with previous studies
showing that either LPS alone or Pam3Cys could provide an
adjuvant effect towards antigen sensitization [14,26]. However, our
observation is novel as it shows that a TLR2 ligand could stimulate
antigen sensitization in the lung directly, since a previous study used
a subcutaneous route for sensitization [26]. We investigated if the
observations we made in CP and killed CP could be generalized
to other bacterial pathogens and we obtained similar allergic
sensitization by UV killed Bordetella bronchiseptica, another pathogen
that has been associated with wheezing and development of allergic
asthma in children. These observations suggest that killed bacteria
other than CP can also induce allergic sensitization, suggesting that
microbial ligands in killed bacteria are most likely able to trigger this
antigen sensitization and play an adjuvant role.
In the current study, we also sought to dissect the role of the
TLR2 and TLR4 in Chlamydia pneumoniae infection-induced allergic
Figure 6. Treg depletion allows high dose CP infection induced antigen sensitization. FoxP3-DTR tg mice received either CP+diphtheria
toxin (DT) (n=9), CP+PBS (n=9), PBS+DT (n=7), or PBS+PBS (n=7), and were sensitized and challenged with HSA as described in Figure 1E.
A: Representative flow cytometric analysis of Treg depletion the day after DT injection. B: Representative staining of lung eosinophils in CP infected
and DT treated mice. C: Representative staining of lung goblet cells in CP infected and DT treated mice. D: Total numbers of eosinophils were related
to the total area of the section. E: Total numbers of goblet cells were related to the total length of bronchial basal membrane in the section.
F: Mediastinal lymph node cells were restimulated with HSA after sensitization. Supernatants were measured for IL-5 by ELISA. G: HSA-specific IgE,
IgG1, and IgG2a titers. *p#0.05, **p#0.01, ***p#0.001.
doi:10.1371/journal.pone.0020784.g006
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the necessary signals in the lung resulting in antigen sensitization.
However, during live CP infection, we observed that only
TLR22/2 mice, but not TLR42/2 mice could be sensitized.
Further investigation revealed a differential Treg response
between these two genotypes; TLR22/2 mice showed reduced
numbers of Tregs in the lung after CP infection, while TLR42/2
had increased numbers of Tregs. These differential Treg responses
likely explain the differential ability for allergic sensitization that
we observed between TLR2- and TLR4-deficient mice. Indeed,
depletion of Tregs in TLR42/2 mice reversed the phenotype
and allowed antigen sensitization in these mice. Furthermore,
reduced Treg numbers in TLR22/2 mice, allowed these mice to
be sensitized even at day 10 after infection, extending the time
window for antigen sensitization relative to the initial infection.
These observations show that allergen sensitization during
bacterial lung infection is regulated by CD4
+ CD25
+ Tregs.
It was previously reported that TLR22/2 mice have reduced
numbers of Tregs in the blood [15]. In fact, additional studies have
shown that TLR2 is critical for expansion, survival, and proper
function of Tregs [16,27,28]. These studies provided us with a
possible explanation for the differences we saw in sensitization
between TLR22/2 and TLR42/2 mice. Indeed, we found
similarly reduced numbers of Tregs in the lungs of TLR22/2
mice. Strikingly, we also found that at the time of sensitization
(5 days after infection), TLR42/2 mice actually had much
greater numbers of Tregs than TLR22/2 or WT mice. To our
knowledge, this is the first report of increased Treg numbers in
TLR42/2 mice during a pulmonary infection. Some recent
studies indicate that TLR4 and TLR2 might have differential
effects on Treg numbers. Zhang et al showed that TLR42/2
mice had increased islet allograft survival due to the presence of
Tregs [29]. While another group found that TLR4 signaling
impaired the expansion of Tregs during a fungal infection [30].
Finally, TLR22/2 and TLR42/2 mice were found to have
opposite phenotypes in a spontaneous model of murine arthritis
[31]. In that study, TLR22/2 mice had reduced FoxP3
expression, greater IL-17 expression, and increase arthritis
severity, while TLR42/2 mice had a lesser severity of arthritis,
and lowered IL-17 expression. Taken together, it is clear that TLR
signaling can have a profound effect on the Treg compartment of
the immune system.
The observation that a severe (high dose) CP infection prevents
antigen sensitization was partially attributed to poor DC
trafficking to the regional lymph nodes and a greater Th1
response with high dose infection [10]. However, in this study, we
also found the numbers of two suppressive cell types, Tregs and
plasmacytoid dendritic cells, were present in the lung in much
greater numbers during the severe infection. It is not surprising
that the numbers of Tregs would increase during the more severe
Figure 7. pDC depletion allows high dose CP infection induced antigen sensitization. A–D: WT mice received either CP+mAB 927 (n=9),
CP+IgG control (n=8), PBS+mAB 927 (n=10), or PBS+IgG control (n=8), and were sensitized and challenged with HSA as described in Figure 1E.
A: Representative flow cytometric analysis of pDC depletion the day after mAB 927 injection. pDCs are indicated in the gated population.
Inflammation (B), Eosinophils (C) and Goblet cells (D) were scored for as before. *p#0.05, **p#0.01, ***p#0.001.
doi:10.1371/journal.pone.0020784.g007
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of an over-exuberant immune response [32]. While pDCs are
known to play an important role in anti-viral responses, they have
also been linked to the activation of Tregs [21,33]. Indeed,
depletion of either cell type during severe pulmonary CP infection
resulted in restoration of the antigen sensitization phenotype
despite the increased Th1 response. Interestingly, the depletion of
pDCs during the severe infection did not alter the numbers of
Tregs in the lung or draining lymph node (data not shown),
indicating that the pDCs suppressive effects were either mediated
by influencing the activity of the Tregs, or by some other
mechanism. These observations are consistent with prior studies,
where the depletion of either Tregs or pDCs in various non-
infectious asthma models has resulted in an increased asthma
response [22,23,34,35].
While most studies of pulmonary bacterial infections and
asthma are directed towards exacerbation, our investigations have
been directed towards the development phase of the disease.
Several other groups have investigated the role of bacterial
infections on antigen sensitization, looking at Chlamydia muridarum,
Streptococcus pneumoniae,o rPorphyromonas gingivalis as their infection
models [36,37,38]. However, all these models employ antigen
sensitization via the intraperitoneal route using an adjuvant such
as alum, and then examine the effects of bacterial infection on that
sensitization. We have chosen to examine the infection itself as the
potential adjuvant and have found, depending on the severity and
timing of the infection, that the same infection can induce or
suppress antigen sensitization. Prevention of C. pneumoniae infection
by vaccination, especially at early ages, might prevent unwanted
allergic sensitizations and the development of asthma. Thus the
development of a C. pneumoniae vaccine could be a desirable
endeavor (with other potentially beneficial effects, such as towards
COPD and atherosclerosis). At early ages children acquire both
bacterial and viral infections and it is of critical importance to
understand the potential mechanisms of antigen sensitization that
might result in the development of asthma. It is logical that Tregs
play such an important role during sensitization and while a
pulmonary bacterial infection can provide an adjuvant effect, that
same infection can result in reduced or greater numbers of Tregs,
which may ultimately control whether allergic sensitization occurs
or not.
Materials and Methods
Ethics Statement
All animal experiments were performed according to the
guidelines and approved protocol (IACUC Protocol #2097) of
the Cedars-Sinai Medical Center Institutional Animal Care and
Use Committee. Cedars-Sinai Medical Center is fully accredited
by the Association for Assessment and Accreditation of Laboratory
Animal Care (AAALAC International) and abides by all applicable
laws governing the use of laboratory animals. Laboratory animals
are maintained in accordance with the applicable portions of the
Animal Welfare Act and the guidelines prescribed in the DHHS
publication, Guide for the Care and Use of Laboratory Animals.
Mice
C57BL/6 mice 8 to 12 weeks of age were used throughout the
study and were housed under specific pathogen free conditions
[10]. In some studies, C57BL/6 mice were acquired from Jackson
Labs (Bar Harbor, ME), while in others, WT littermate controls
were used. TLR22/2 and TLR42/2 mice (provided by Shizuo
Akira, Osaka, Japan) were backcrossed to C57BL/6 background
for at least 8 generations and bred at our facility. FoxP3-DTR-tg
mice were acquired from Alexander Rudensky (Sloan-Kettering
Cancer Center, NY) and were backcrossed to C57BL/6
background for at least 8 generations.
Infection with C. pneumoniae
Chlamydia pneumoniae CM-1 (ATCC, Manassas, VA) was
propagated in HEp-2 cells as previously described [11]. HEp-2
cells and C. pneumoniae stocks were determined to be free of
Mycoplasma contamination by PCR. Mice were intranasally
infected with C. pneumoniae by inoculating with 40 ml of PBS
containing either 5610
5 or 5610
6 IFU of the microorganism.
Allergen sensitization and assessment of eosinophilic
airway inflammation
Human serum albumin (HSA) (low endotoxin, Sigma, St Louis,
Mo) was used as an antigen throughout the study as described
earlier [10] in order to reduce the possibility of LPS contamination
[39]. HSA on its own does not induce allergic airway sensitization
and is completely inert [10,39]. Mice previously infected with C.
pneumoniae received 100 mg of HSA in PBS (sensitization) intra-
nasally on 3 consecutive days, starting at various time points after
infection, as indicated in the text and figures (Fig S1). Control
groups received PBS only. On days 15, 16, 19, and 20 after initial
sensitization, mice were re-exposed to 25 mg HSA (challenge)
intranasally as above. Mice were sacrificed on day 21 and sera and
lungs were harvested. The right lobes of the lungs were fixed in
10% formalin, and paraffin-embedded and hematoxylin and
eosin–stained sections were evaluated. The degree of inflammation
was scored by a blinded pathologist, as described previously [11].
Goblet cells were detected by means of periodic acid–Schiff
staining. For assessment of eosinophilic airway inflammation, the
left lobe was fixed in PBS/2% paraformaldehyde/0.2% picric
acid, and 7 mm cryosections were prepared. Eosinophils were
detected by means of eosinophil peroxidase– specific staining, as
described previously [40]. Data were expressed as the number of
eosinophils per square millimeter lung section, as well as the
number of goblet cells per millimeter of bronchial basal membrane
using Image Pro Plus 5.1 Software (Media Cybernetics, Bethesda,
MD) to measure the lung area and the bronchial basal membrane
length respectively as reported previously [10]. For some
experiments, mice were sensitized with HSA plus LPS (100 ng: a
protein-free preparation derived from Escherichia coli K235, kindly
provided by S.N. Vogel, University of Maryland, Baltimore, MD),
Pam2Cys lipopeptide (100 ng: EMC microcollections, Tu ¨bingen,
Germany). In some experiments, 1 mg diphtheria toxin (Sigma,
MO) was injected i.p. twice, one day before sensitization and on
the second day of sensitization, to deplete Tregs in FoxP3-DTR-tg
mice. In other experiments using TLR4-deficient mice, 100 mg
PC61 antibody (BioLegend, San Diego, CA) was injected i.p. into
mice one day before sensitization to deplete Tregs. One injection
could deplete Tregs for at least 4 days [10]. For other experiments,
500 mg mAB 927 (pDC depleting mAB 927 was provided to us by
Marco Colonna, Washington University, MO) [24] was injected
i.p. twice, one day before sensitization and on the second day of
sensitization, to deplete pDCs in mice. Rat IgG from serum was
used as antibody controls (Sigma, MO).
Flow cytometry
Total lung cell preparations from mice infected with C.
pneumoniae were prepared by digesting lungs with 100 mg/mL
Blendzyme 3 (Roche, Mannheim, Germany) and 20 mg/mL
DNAseI (Roche). Cell suspensions were prepared as published
earlier [10]. Numbers of pDCs in the lungs were identified as
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in the lungs were identified as CD4 CD25 FoxP3 positive. Bone
marrow dendritic cells were identified as CD11b CD11c positive
and F4/80 negative. CD11b PerCP Cy5.5, CD11c E450, CD19
PE-Cy5, CD3 PE-Cy5, CD4 PE-Cy5, B220 PE, FoxP3 PE, F4/80
APC, and CD25 FITC were all purchased from eBioscience (San
Diego, CA). 120g8 APC (BST2) was purchased from Imgenex
(San Diego, CA). Surface expression of CD80 and CD86 on
BMDCs was determined using flow cytometry. CD80 FITC and
CD86 FITC were purchased from eBioscience. Flow cytometric
analysis was performed using a FACScan flow cytometer (BD
Biosciences, San Jose, CA), or a CYAN flow cytometer (Dako,
Carpinteria, CA) and the data was analyzed using Summit (Dako,
Carpinteria, CA, USA).
Determination of HSA-specific immunoglobulins
HSA-specific immunoglobulins were determined as described
previously [10]. Details are provided in the On Line Repository
for this article.
UV Inactivation of Bacteria
For UV-inactivation, chlamydial suspensions were placed under
a UV lamp (15 W at 30 cm) for 15 min. UV-inactivation was
confirmed by subculturing of treated bacteria in HEp-2 cells.
Bordetella bronchiseptica (provided by Dr. Jeff Miller, UCLA, CA) was
UV-inactivated as above.
Bone marrow–derived DCs
Bone marrow–derived dendritic cells (BMDCs) were generated
by incubating bone marrow cells with 10 ng/ml recombinant
mouse GM-CSF (Biosource, Bethesda, MD) for 6 days, with
medium changes at days 3 and 5. DCs were harvested at day 6
and purified with CD11c microbeads, as described above. Purity
was assessed by means of flow cytometry was routinely around
98%.
Cytokine detection
2610
5 mediastinal lymph node cells were stimulated with HSA
(200 mg/ml) for three days and supernatants collected. IL-5 levels
were determined by ELISA (eBioscience). BMDCs were incubated
with either CP, LPS (InvivoGen, San Diego, CA), or LP2
(Pam2CSK4) (InvivoGen), and supernatants collected. Levels of
IL-6 were determined by ELISA (BD Biosciences).
Determination of HSA-specific immunoglobulins
For HSA-specific IgG1 and IgG2a titers, plates were coated
with 50 mg/mL HSA overnight, followed by blocking with PBS/
1% BSA at 37uC for 30 minutes. Plates were incubated with
serum samples diluted in PBS/1% BSA at 37uC for 90 minutes,
followed by detection of bound immunoglobulin with biotinylated
anti-mouse IgG1 and IgG2a antibodies, respectively (BD Biosci-
ences), and streptavidin (eBioscience). For HSA- specific IgE, HSA
was biotinylated with the FluoreporterBiotin-XX kit (Invitrogen,
Carlsbad, CA). Plates were coated with anti-mouse IgE antibody
(BD Biosciences), blocked with BSA, and incubated with serum
samples. Bound HSA-specific IgE was detected by using
biotinylated HSA and streptavidin-HRP. As a standard, pooled
sera from mice immunized with HSA plus LPS was used and set
arbitrarily at 1.0 U/ml.
Statistical analyses
Independent experiments were conducted at least in triplicate,
except as otherwise noted. Data are reported as mean values
6SEM and compared by using 2-tailed unpaired Student’s t test.
For multiple comparison test, statistical significance was evaluated
by one or two-way ANOVA with Tukey’s post-hoc test where
appropriate. A p value of less than 0.05 was required to reject the
null hypothesis.
Supporting Information
Figure S1 Sensitization and challenge protocols. A:
CPUV protocol. Starting with day 0, groups of mice received
intranasal injections of 100 mg HSA with or without 1610
6 UV-
inactivated CP on 3 consecutive days (or LPS, or LP2). Control
groups received HSA plus a mock extract of HEp-2 cells or CPUV
only. At day 15, mice received 4 intranasal injections of 25 mg
HSA. A control group received PBS. Mice were sacrificed 24 h
after the final challenge. B: CP infection protocol. At day 25
either 5610
5 or 5610
6 IFU CP were injected intranasally to mice.
5 days later the mice were sensitized, challenged, and sacrificed as
above. C: Depletion protocols. At day 25 either 5610
5 or
5610
6 IFU CP were injected intranasally to mice. Either
diphtheria toxin, mAB 927, or mAB PC61 were injected i.p. into
mice on the days indicated to deplete Tregs, plasmacytoid
dendritic cells, and Tregs respectively. The mice were sensitized
and challenged as before.
(TIF)
Figure S2 UV-killed Bordetella bronchiseptica (BBUV)
induces airway allergic sensitization to human serum
albumin (HSA). Mice were sensitized as indicated in Figure
E1A. A: Inflammatory scores of H&E stained lung sections of mice
after sensitization and challenge. B: BBUV-sensitized (n=15) and
PBS control (n=9) eosinophil numbers per lung section area
(mm
2), representative peroxidase-stained sections (100-fold mag-
nification) are shown. C: BBUV-sensitized (n=9) and PBS control
(n=5) goblet cell numbers per basal membrane length (mm),
representative periodic acid-Schiff-stained sections (100-fold mag-
nification) are shown. D: HSA-specific IgE, IgG1, and IgG2a
relative titers. *p#0.05, **p#0.01, ***p#0.001.
(TIF)
Figure S3 Innate immune responses in TLR knockout
BMDCs. A: IL-6 expression in BMDCs from wild type,
TLR22/2, TLR42/2, and MyD882/2 mice. DCs were
infected with CP (MOI=2.5), or exposed to CPUV (MOI2.5),
LPS (100 ng/ml), or LP2 (100 ng/ml) for 24 hr. IL-6 was
measured by ELISA in the supernatants. B: Up-regulation of
costimulatory molecules on BMDCs from wild type, TLR22/2
and TLR42/2 mice. DCs were infected with CP (MOI=2.5)
and expression of CD80 and CD86 were determined by FACS
after 24 h. Shown are data from uninfected controls (bold line),
infected cells (dotted lines), and isotype controls (in grey).
(TIF)
Figure S4 Quantization of Tregs and pDCs in the lung.
A: The total number of lung Tregs in wild type, TLR22/2, and
TLR42/2 uninfected and CP-infected mice. Wild type,
TLR42/2, and TLR22/2 mice (n=3–6 per group) were
inoculated with 5610
5 IFU of CP. 5 days after inoculation, mice
were sacrificed, lung leukocyte preparations were generated and
analyzed for the presence of CD4+, CD25+, Foxp3+ Tregs by
flow cytometry. B: Tregs were assessed in the lungs of WT and
TLR22/2 mice 10 days after low dose (5610
5) CP infection.
Data are presented as the total count of CD4+, CD25+, FoxP3+
Tregs in the lung. C–F: WT mice were infected with either low
dose (5610
5) or high dose (5610
6) CP intranasally. 5 days after
infection, the lungs were harvested and single cell suspensions were
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count of CD4+, CD25+, FoxP3+ Tregs in the lung. D: pDCs.
Data are presented as BST2+, B220+, CD3 CD19 CD11b- and
side scatter low as a total pDC cell count in the lung. E–F:
Representative Flow cytometric scatter plots for Tregs and pDCs
in mouse Lungs during CP infection. E: Tregs. Data are presented
as CD4+, CD25+, FoxP3+ Tregs. F: pDCs. Data are presented as
BST2+, B220+, CD3 CD19 CD11b- and side scatter low.
*p#0.05, **p#0.01, ***p#0.001.
(TIF)
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